nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—DRD2—Signaling Pathways—CDKN2B—melanoma	0.000188	0.000188	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KDR—melanoma	0.000188	0.000188	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB4—melanoma	0.000187	0.000187	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MAPK3—melanoma	0.000187	0.000187	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CB—melanoma	0.000186	0.000186	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN2B—melanoma	0.000185	0.000185	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP17A1—melanoma	0.000185	0.000185	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—BRAF—melanoma	0.000183	0.000183	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD86—melanoma	0.000182	0.000182	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL8—melanoma	0.000182	0.000182	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FN1—melanoma	0.000181	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDN1—melanoma	0.000181	0.000181	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD86—melanoma	0.000179	0.000179	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL8—melanoma	0.000179	0.000179	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1—melanoma	0.000179	0.000179	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—MAPK1—melanoma	0.000178	0.000178	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDN1—melanoma	0.000178	0.000178	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EGFR—melanoma	0.000178	0.000178	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOTCH1—melanoma	0.000177	0.000177	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CSF2—melanoma	0.000177	0.000177	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF1—melanoma	0.000177	0.000177	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GNA11—melanoma	0.000175	0.000175	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2—melanoma	0.000174	0.000174	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CSF2—melanoma	0.000174	0.000174	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF1—melanoma	0.000174	0.000174	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CD80—melanoma	0.000174	0.000174	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KIT—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APC—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CG—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—NRAS—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—E2F1—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAP2K1—melanoma	0.000173	0.000173	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CB—melanoma	0.000172	0.000172	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CD—melanoma	0.000172	0.000172	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGF—melanoma	0.000171	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—melanoma	0.000171	0.000171	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—FASN—melanoma	0.000171	0.000171	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDGFRA—melanoma	0.000171	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—E2F1—melanoma	0.00017	0.00017	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PIK3CA—melanoma	0.00017	0.00017	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ITGB3—melanoma	0.000169	0.000169	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PRKCA—melanoma	0.000169	0.000169	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CB—melanoma	0.000169	0.000169	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC5A5—melanoma	0.000168	0.000168	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDGFRA—melanoma	0.000168	0.000168	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—KRAS—melanoma	0.000168	0.000168	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PRKCA—melanoma	0.000167	0.000167	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ITGB3—melanoma	0.000167	0.000167	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SPP1—melanoma	0.000166	0.000166	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK3—melanoma	0.000166	0.000166	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAP2K2—melanoma	0.000166	0.000166	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—melanoma	0.000165	0.000165	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FGF2—melanoma	0.000164	0.000164	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SPP1—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—BRAF—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAP2K2—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GNAQ—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD44—melanoma	0.000163	0.000163	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—melanoma	0.000159	0.000159	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—melanoma	0.000158	0.000158	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—MAPK1—melanoma	0.000158	0.000158	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—melanoma	0.000158	0.000158	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TERT—melanoma	0.000157	0.000157	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAC1—melanoma	0.000157	0.000157	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1B1—melanoma	0.000156	0.000156	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—melanoma	0.000155	0.000155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TERT—melanoma	0.000155	0.000155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAC1—melanoma	0.000154	0.000154	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PIK3CA—melanoma	0.000154	0.000154	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MDM2—melanoma	0.000154	0.000154	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAP2K1—melanoma	0.000153	0.000153	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CD—melanoma	0.000152	0.000152	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ERBB2—melanoma	0.000152	0.000152	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PIK3CA—melanoma	0.000151	0.000151	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HIF1A—melanoma	0.000151	0.000151	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CB—melanoma	0.00015	0.00015	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—KRAS—melanoma	0.000149	0.000149	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HIF1A—melanoma	0.000148	0.000148	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FGF2—melanoma	0.000146	0.000146	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KDR—melanoma	0.000144	0.000144	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—melanoma	0.000144	0.000144	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HRAS—melanoma	0.000143	0.000143	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KDR—melanoma	0.000142	0.000142	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1B—melanoma	0.00014	0.00014	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—melanoma	0.000139	0.000139	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FN1—melanoma	0.000139	0.000139	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—melanoma	0.000138	0.000138	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—melanoma	0.000137	0.000137	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3CA—melanoma	0.000137	0.000137	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—melanoma	0.000137	0.000137	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MDM2—melanoma	0.000137	0.000137	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FN1—melanoma	0.000136	0.000136	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOTCH1—melanoma	0.000136	0.000136	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ERBB2—melanoma	0.000135	0.000135	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCND1—melanoma	0.000134	0.000134	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOTCH1—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CD80—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CB—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APC—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CG—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KIT—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—NRAS—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CTNNB1—melanoma	0.000133	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGF—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CD80—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APC—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KIT—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CG—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—NRAS—melanoma	0.000131	0.000131	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—melanoma	0.00013	0.00013	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CDKN1A—melanoma	0.000129	0.000129	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PTEN—melanoma	0.000129	0.000129	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGF—melanoma	0.000129	0.000129	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NFKB1—melanoma	0.000129	0.000129	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ABCB1—melanoma	0.000128	0.000128	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—melanoma	0.000128	0.000128	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK3—melanoma	0.000127	0.000127	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HRAS—melanoma	0.000127	0.000127	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—melanoma	0.000126	0.000126	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK3—melanoma	0.000125	0.000125	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—BRAF—melanoma	0.000125	0.000125	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1B—melanoma	0.000125	0.000125	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—melanoma	0.000123	0.000123	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—BRAF—melanoma	0.000123	0.000123	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—melanoma	0.000122	0.000122	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—melanoma	0.000122	0.000122	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—melanoma	0.000121	0.000121	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—melanoma	0.000121	0.000121	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—MAPK1—melanoma	0.000121	0.000121	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—melanoma	0.000121	0.000121	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—melanoma	0.000119	0.000119	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—MAPK1—melanoma	0.000119	0.000119	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCND1—melanoma	0.000119	0.000119	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—melanoma	0.000119	0.000119	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PRKCA—melanoma	0.000118	0.000118	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CTNNB1—melanoma	0.000118	0.000118	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAP2K1—melanoma	0.000117	0.000117	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ERCC2—melanoma	0.000117	0.000117	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—melanoma	0.000117	0.000117	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CD—melanoma	0.000117	0.000117	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STAT3—melanoma	0.000116	0.000116	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3CA—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAP2K1—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NRAS—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN1A—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PTEN—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CD—melanoma	0.000115	0.000115	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NFKB1—melanoma	0.000114	0.000114	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—KRAS—melanoma	0.000114	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	0.000114	0.000114	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—KRAS—melanoma	0.000112	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—melanoma	0.000112	0.000112	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FGF2—melanoma	0.000112	0.000112	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK3—melanoma	0.00011	0.00011	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FGF2—melanoma	0.00011	0.00011	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MYC—melanoma	0.000107	0.000107	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MAPK1—melanoma	0.000105	0.000105	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—melanoma	0.000105	0.000105	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3CA—melanoma	0.000105	0.000105	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MDM2—melanoma	0.000104	0.000104	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—melanoma	0.000104	0.000104	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3CA—melanoma	0.000103	0.000103	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB2—melanoma	0.000103	0.000103	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MDM2—melanoma	0.000103	0.000103	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STAT3—melanoma	0.000103	0.000103	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NRAS—melanoma	0.000102	0.000102	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CB—melanoma	0.000102	0.000102	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB2—melanoma	0.000101	0.000101	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CB—melanoma	0.0001	0.0001	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KRAS—melanoma	9.92e-05	9.92e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK3—melanoma	9.81e-05	9.81e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—melanoma	9.77e-05	9.77e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HRAS—melanoma	9.7e-05	9.7e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—melanoma	9.61e-05	9.61e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HRAS—melanoma	9.55e-05	9.55e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MYC—melanoma	9.54e-05	9.54e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1B—melanoma	9.54e-05	9.54e-05	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—melanoma	9.43e-05	9.43e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1B—melanoma	9.38e-05	9.38e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—melanoma	9.35e-05	9.35e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—melanoma	9.33e-05	9.33e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MAPK1—melanoma	9.33e-05	9.33e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—melanoma	9.33e-05	9.33e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—melanoma	9.29e-05	9.29e-05	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—melanoma	9.28e-05	9.28e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CG—melanoma	9.25e-05	9.25e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—melanoma	9.2e-05	9.2e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—melanoma	9.18e-05	9.18e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—melanoma	9.14e-05	9.14e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3CA—melanoma	9.12e-05	9.12e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCND1—melanoma	9.1e-05	9.1e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CTNNB1—melanoma	9.01e-05	9.01e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCND1—melanoma	8.95e-05	8.95e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARG—melanoma	8.93e-05	8.93e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CTNNB1—melanoma	8.87e-05	8.87e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—melanoma	8.83e-05	8.83e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TP53—melanoma	8.82e-05	8.82e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KRAS—melanoma	8.81e-05	8.81e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN1A—melanoma	8.8e-05	8.8e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTEN—melanoma	8.78e-05	8.78e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NFKB1—melanoma	8.74e-05	8.74e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—melanoma	8.69e-05	8.69e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN1A—melanoma	8.66e-05	8.66e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTEN—melanoma	8.64e-05	8.64e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NFKB1—melanoma	8.6e-05	8.6e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—melanoma	8.57e-05	8.57e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HRAS—melanoma	8.43e-05	8.43e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—melanoma	8.43e-05	8.43e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CD—melanoma	8.13e-05	8.13e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3CA—melanoma	8.1e-05	8.1e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—melanoma	8.07e-05	8.07e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—melanoma	8.03e-05	8.03e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—melanoma	7.93e-05	7.93e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STAT3—melanoma	7.85e-05	7.85e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NRAS—melanoma	7.83e-05	7.83e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TP53—melanoma	7.83e-05	7.83e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—melanoma	7.8e-05	7.8e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STAT3—melanoma	7.73e-05	7.73e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NRAS—melanoma	7.71e-05	7.71e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK3—melanoma	7.5e-05	7.5e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HRAS—melanoma	7.49e-05	7.49e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—melanoma	7.45e-05	7.45e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK3—melanoma	7.38e-05	7.38e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MYC—melanoma	7.3e-05	7.3e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MYC—melanoma	7.18e-05	7.18e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—melanoma	7.17e-05	7.17e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MAPK1—melanoma	7.14e-05	7.14e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—melanoma	7.14e-05	7.14e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CB—melanoma	7.09e-05	7.09e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MAPK1—melanoma	7.03e-05	7.03e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—melanoma	7.02e-05	7.02e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—melanoma	7.02e-05	7.02e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KRAS—melanoma	6.74e-05	6.74e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KRAS—melanoma	6.64e-05	6.64e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—melanoma	6.61e-05	6.61e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3CA—melanoma	6.2e-05	6.2e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTEN—melanoma	6.13e-05	6.13e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3CA—melanoma	6.1e-05	6.1e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TP53—melanoma	5.99e-05	5.99e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TP53—melanoma	5.9e-05	5.9e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HRAS—melanoma	5.73e-05	5.73e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HRAS—melanoma	5.64e-05	5.64e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—melanoma	5.49e-05	5.49e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—melanoma	5.4e-05	5.4e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—melanoma	5.06e-05	5.06e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—melanoma	4.98e-05	4.98e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3CA—melanoma	4.32e-05	4.32e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—melanoma	3.53e-05	3.53e-05	CbGpPWpGaD
